Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study

Atogepant 60 mgOngoingRecruitingPhase 4Open NCT06972056 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…

NCT06972056 · Trial Tracker · ComplyRx